Straits Times Index
3,110.73 +36.47 (+1.19%) S&P 500
4,604.37 +18.78 (+0.41%) Dow
36,247.87 +130.49 (+0.36%) Nasdaq
14,403.97 +63.98 (+0.45%) Bitcoin USD
43,782.37 -194.18 (-0.44%) CMC Crypto 200
914.81 +18.10 (+2.02%)
ABBV Jan 2024 165.000 put
| Previous close | 26.59 |
| Open | 26.59 |
| Bid | 16.10 |
| Ask | 16.95 |
| Strike | 165.00 |
| Expiry date | 2024-01-19 |
| Day's range | 26.59 - 26.59 |
| Contract range | N/A |
| Volume | |
| Open interest | 156 |
Insider Monkey12 Healthcare Stocks Billionaires Like the Most
In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, […]
Motley Fool4 Top Dividend Stocks Yielding More Than 4% to Buy Hand-Over-Fist This December
Many dividend stocks have sold off over the past year. Higher interest rates made lower-risk investments like bonds and bank CDs more attractive income-generating options. On the bright side, income-seeking investors can lock in some pretty attractive dividend yields these days.
Motley FoolAbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
AbbVie's share price reflected the concerns. AbbVie's executives and business development team have been quite busy lately. On Nov. 30, AbbVie announced its plans to acquire ImmunoGen (NASDAQ: IMGN) in an all-cash transaction valued at roughly $10.1 billion.
